On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Wednesday, September 17, 2025

Industry-Sponsored N-of-1 Trials in Orphan Drug Development

›
N-of-1 clinical trial is often mentioned as one of the approaches to address the challenging issues in orphan drug development. at one point...
Monday, September 15, 2025

Steroid Tapering Design in Action - Failed

›
In a previous post, I discussed steroid tapering design clinical trials . In these trials, the primary efficacy endpoint is the reduction in...
Sunday, July 20, 2025

ICH E21 "Inclusion of Pregnant and Breastfeeding Individuals in Clinical Trials"

›
US FDA has just endorsed the draft guideline of ICH E21 " Inclusion of Pregnant and Breastfeeding Individuals in Clinical Trials "...
2 comments:
Friday, July 04, 2025

Rank Analysis of Covariance (RANK ANCOVA) versus Aligned Rank Stratified Wilcoxon Test

›
In clinical trials where outcome measures violate the assumptions required for parametric statistical methods such as analysis of covariance...
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.